random studi on-lin plasma perfus protein a-sepharos chemotherapi patient metastat colorect carcinoma safeti on-lin plasma perfus protein-a sepharos therapeut advantag plasma perfus PP protein-a sepharos chemotherapi patient metastat colorect carcinoma mcrc thirti patient surgeri primari crc combin PP protein-a sepharos group combin PP sepharos group alon group bi-weekli on-lin PP ml protein-a sepharos gel group ml sepharos gel group cobe blood cell separ maximum treatment patient day cycl progress PP sever life-threaten toxic mild clinic side-effect fever chill group group common biolog effect PP protein-a sepharos signific drop igg pre-pp valu pre-pp valu signific gener anaphylatoxin tumor respons rate group group group median surviv time group month group month group month first random trial therapeut advantag PP protein-a sepharos convent chemotherapi mcrc 